InvestorsHub Logo

survivor1x

05/31/19 3:24 PM

#230115 RE: survivor1x #230114

The lemon I was referring to is pseudoprogression.

beartrap12

05/31/19 3:33 PM

#230122 RE: survivor1x #230114

Exactly, Survivor. I see this trial is 2017. I believe I saw it back then. I’m hoping it can be an early signal that the immunotherapy is working so as to shorten trials. As you noted.

Doc logic

05/31/19 5:31 PM

#230153 RE: survivor1x #230114

survivor1x,

I suppose it is one if several things being introduced as ancillary evidence in the L SAP. Hence the need for very mature data to strengthen correlations to survival based on various observations. This being accepted would lead to acceptance in Direct trials along with use of evidence found in the patent claims related to known responders. This wait will be proven to be well worth it.
Best wishes.